3-Chloro-4-methoxybenzylamine hydrochloride CAS: 41965-95-1
| Product Parameters | |
|---|---|
| Catalog No. | BK3SR1 |
| CAS.RN | 41965-95-1 |
| Molecular Formula | C8H11Cl2NO |
| Molecular Weight | 208.09 g/mol |
| Purity | NLT 98% |
Product Overview
3-Chloro-4-methoxybenzylamine hydrochloride, as a pharmaceutical intermediate, is widely used in the synthesis of antitumor, antiviral, and central nervous system drugs, and is an important precursor for constructing chlorinated and methoxy-substituted benzene ring structures. This product is suitable for small-scale preparation, pilot-scale amplification, and commercial production in the R&D stage. It possesses good chemical stability and reactivity, meeting the needs of process development at different scales and providing customers with an efficient and reliable raw material supply.
Applications
- Synthesis of antitumor drugs containing chloromethoxyphenyl structures
- Construction of key intermediates for antiviral drugs
- Synthesis of molecular skeletons for central nervous system drugs
- Customized synthesis and process optimization of pharmaceutical intermediates
- Research on drug molecule structure modification and functionalization
Quality & Supply Capability
English Name: 3-Chloro-4-methoxybenzylamine hydrochloride Properties: White to off-white crystalline powder, readily soluble in organic solvents, possessing a stable aromatic ring structure and reactive amino functional groups, suitable for various organic synthesis reactions. Storage Recommendations: Store in a sealed, light-protected, and dry place, subject to the COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process service from laboratory sample supply to small-scale preparation, pilot-scale amplification, and customized batch production. We can flexibly adjust the supply plan according to customer requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documentation. We also have a professional technical support team to assist customers in process development, route optimization, and project transformation, ensuring the stability and applicability of the product at different stages.
Why Choose Bioncan
Focused on pharmaceutical intermediates, possessing extensive synthesis experience and technological expertise. Full-scale supply capability, covering needs from laboratory to commercial production. Provides complete quality control documentation support, including COA, MSDS, HPLC, NMR, etc. Supports customized needs, adjusting purity, impurity standards, and packaging according to customer requirements. Provides supporting process optimization and project scale-up technologies to help customers achieve efficient transformation and mass production.
Intermediates of Avanafil
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA23C3 | Avanafil API | 330784-47-9 |
| BK0S6Q | 2-aMinomethylpyrimidine Hydrochloride | 372118-67-7 |
| BK31MB | Ethyl 4-chloro-2-methylthio-5-pyrimidinecarboxylate | 5909-24-0 |
| BK3SR1 | 3-Chloro-4-methoxybenzylamine hydrochloride | 41965-95-1 |
| BK61M7 | 4-[[(3-Chloro-4-methoxyphenyl)methyl]amino]-2-(methylthio)-5-pyrimidinecarboxylic acid ethyl ester | 330785-81-4 |
| BK7D52 | 4-[[(3-Chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-5-pyrimidinecarboxylic acid ethyl ester | 330785-83-6 |
| BK9XB6 | 4-[[(3-Chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-5-pyrimidinecarboxylic acid | 330785-84-7 |
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 41965-95-1, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.